Schedule 13G ownership disclosure

EUPRAXIA PHARMACEUTICALS INC

Common Shares · CUSIP: 29842P105

Event date: 2024-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • MANCHESTER MANAGEMENT COMPANY, LLC

    Shares: 5,562,971.00 · Class: 10.4%

  • MANCHESTER MANAGEMENT PR, LLC

    Shares: 5,562,971.00 · Class: 10.4%

  • MANCHESTER EXPLORER, L.P.

    Shares: 5,337,117.00 · Class: 10.0%

  • JAMES E. BESSER

    Shares: 5,839,557.00 · Class: 10.9%

  • MORGAN C. FRANK

    Shares: 5,644,423.00 · Class: 10.6%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000919574-25-006637
Form type
SCHEDULE 13G
Filer
EUPRAXIA PHARMACEUTICALS INC.
CIK
CIK 1581178
Filed
Nov 13, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub